Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death
Trinayan Kashyap(Karyopharm Therapeutics (United States)), Yosef Landesman(Karyopharm Therapeutics (United States))
Cited by 129